Epileptogenic activity of methicillin-resistant Staphylococcus aureus (MRSA) antibiotics in rats

Ashequr Rahman1, Jun Ago, Naotaka Matsumoto

  • 1Department of Medicinal Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tsushima-naka, Okayama, Japan.

Insights

Teicoplanin induced dose-related seizures in rats, while vancomycin showed minimal epileptogenic activity. This suggests vancomycin is safer for treating methicillin-resistant Staphylococcus aureus (MRSA) infections.

Area of Science:

  • Neuropharmacology
  • Infectious Diseases

Background:

  • Antibiotics are crucial for treating infections, but their central nervous system (CNS) effects require careful evaluation.
  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant treatment challenge, necessitating effective antibiotic options.

Purpose of the Study:

  • To investigate the epileptogenic potential of antibiotics used against MRSA.
  • To compare the CNS effects of teicoplanin and vancomycin following intracerebroventricular administration.

Main Methods:

  • Rats with chronic electrodes received intracerebroventricular (i.c.v.) injections of various antibiotics.
  • Electroencephalographic (EEG) recordings and behavioral observations were used to assess epileptogenic activity.
  • Dose-response relationships for teicoplanin, vancomycin, fosfomycin, cefazolin, and penicillin G were evaluated.

Main Results:

  • Teicoplanin induced dose-dependent EEG seizures and convulsions.
  • Vancomycin exhibited minimal to no epileptogenic activity, even at high doses.
  • Reference antibiotics like fosfomycin, cefazolin, and penicillin G also showed dose-dependent epileptogenic effects.

Conclusions:

  • Teicoplanin possesses potent epileptogenic activity, distinct from vancomycin.
  • Vancomycin appears to be safe concerning epileptogenic activity for clinical use in MRSA infections.